Mercer Global Advisors
XERS icon

Mercer Global Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

Mercer Global Advisors’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98.5K Buy
+16,988
New +$113K ﹤0.01% 3021
2025
Q4 		– Sell
-10,466
Closed -$85.2K – 2974
2025
Q3 		$85.2K Buy
+10,466
New +$69.5K ﹤0.01% 2543

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mercer Global Advisors's XERS Position: Q1 2026 in Review

Mercer Global Advisors opened a new position in Xeris Biopharma Holdings (XERS) in Q1 2026: 16,988 shares worth $98.5K. The stake represents ﹤0.01% of the portfolio and ranks #3021 among its holdings. This is a return to the name: Mercer Global Advisors previously reported a position in XERS as recently as Q3 2025.

Mercer Global Advisors first reported a position in XERS in Q3 2025 and has held it in 2 quarters since. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Mercer Global Advisors held 16,988 shares of Xeris Biopharma Holdings worth $98.5K as of Q1 2026.
  • Xeris Biopharma Holdings was a new Mercer Global Advisors position in Q1 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #3021 holding.
  • Mercer Global Advisors first reported a position in Xeris Biopharma Holdings in Q3 2025 and has held it in 2 quarters since.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.